Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study
- 144 Downloads
The aim of this study was to evaluate the associations between malnutrition and the clinical features of the disease and depression in patients with systemic sclerosis (SSc).
Patients with SSc who were followed up in our clinic were enrolled in the study. Malnutrition risk was assessed using the Malnutrition Universal Screening Tool (MUST). Skin involvement was assessed using the modified Rodnan skin score (mRSS) and interincisal distance (ID) measurements were used to assess the maximal mouth opening capacity. The Beck Depression Inventory (BDI) was used for measuring the severity of depression.
Ninety-eight patients with SSc (84.7% women; mean age 52.67 ± 11.26 years) were included in the study. According to the MUST scores, 61.2%, 15.3%, and 23.5% of patients had low, medium, and high risk for malnutrition, respectively. The mRSS was significantly higher in the group with high malnutrition risk compared with low-risk group (p = 0.014). Malnutrition risk was associated with interstitial lung disease and bowel involvement (p = 0.044 and p = 0.021, respectively). Interincisal distance was lower in the group with high malnutrition risk compared with the low-risk group (p = 0.003). Malnutrition risk was higher in patients who had mild-to-severe depressive symptoms than in those without (p = 0.012). Interincisal distance and bowel involvement were the most relevant factors for malnutrition.
The risk of malnutrition is increased in patients with SSc. In our study, microstomia and bowel involvement were the most relevantly associated factors with malnutrition.
• The risk of malnutrition is increased in patients with systemic sclerosis (SSc).
• Microstomia and bowel involvement are found to be the most important factors associated with malnutrition.
• Depressive symptoms are seen frequently among patients with SSc, and depression seems to be one of the etiologic factors or the result of malnourishment in SSc.
• Assessment of nutritional status and the presence of depression should be a part of routine clinical visits of patients with SSc.
KeywordsDepression Gastrointestinal involvement Interincisal distance Malnutrition Systemic sclerosis
Compliance with ethical standards
The study was conducted in accordance with the original Declaration of Helsinki and its later amendments or comparable ethical standards and was approved by the local ethics committee (date, 4 November 2016; reference number, 58/7). Informed consent was received from all the patients.
- 3.Codullo V, Cereda E, Crepaldi G, Cappello S, Montecucco C, Caccialanza R, Caporali R (2015) Disease-related malnutrition in systemic sclerosis: evidences and implications. Clin Exp Rheumatol 33:190–194Google Scholar
- 4.Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U, Haeupl T, Hanke K, Hensel-Wiegel K, Ebert H, Ziemer S, Ladner UM, Pirlich M, Burmester GR, Riemekasten G (2010) Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69(11):1951–1957PubMedGoogle Scholar
- 5.Harrison E, Herrick AL, McLaughlin JT, Lal S (2012) Malnutrition in systemic sclerosis. Rheumatology (Oxford) 51(10):1747–1756Google Scholar
- 6.Baron M, Bernier P, Côté LF, Delegge MH, Falovitch G, Friedman G, Gornitsky M, Hoffer J, Hudson M, Khanna D, Paterson WG, Schafer D, Toskes PP, Wykes L (2010) Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. Clin Exp Rheumatol 28:42–46Google Scholar
- 7.McFarlane IM, Bhamra MS, Kreps A et al (2018) Gastrointestinal manifestations of systemic sclerosis. Rheumatology (Sunnyvale) 8(1):235Google Scholar
- 8.Gyger G, Baron M (2015) Systemic sclerosis: gastrointestinal disease and its management. Rheum Dis Clin N Am 41(3):459–473Google Scholar
- 10.Bolster MB, Silver RM (2011) Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weismann MH (eds) Rheumatology, 5th edn. Mosby, Philadelphia, p 1383Google Scholar
- 11.Baubet T, Ranque B, Taïeb O, Bérezné A, Bricou O, Mehallel S, Moroni C, Belin C, Pagnoux C, Moro MR, Guillevin L, Mouthon L (2011) Mood and anxiety disorders in systemic sclerosis patients. Presse Med 40(2):111–119Google Scholar
- 12.Thombs BD, Fuss S, Hudson M, Schieir O, Taillefer SS, Fogel J, Ford DE, Baron M, Canadian Scleroderma Research Group (2008) High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum 59(3):431–437PubMedGoogle Scholar
- 14.LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Cleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205Google Scholar
- 15.Furst DE, Clements PJ, Steen VD et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88Google Scholar
- 16.Torok KS, Baker NA, Lucas M, Domsic RT, Boudreau R, Medsger TA Jr (2010) Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clin Exp Rheumatol 28:28–36Google Scholar
- 18.Bartoli F, Fiori G, Braschi F, Amanzi L, Bruni C, Blagojevic J, Bellando-Randone S, Cometi L, de Souza Mueller C, Guiducci S, Rasero L, Epifani F, Furst DE, Matucci-Cerinic M (2016) Calcinosis in systemic sclerosis: subsets, distribution and complications. Rheumatology (Oxford) 55:1610–1614Google Scholar
- 19.Tolosa-Vilella C, Morera-Morales ML, Simeón-Aznar CP, Marí-Alfonso B, Colunga-Arguelles D, Callejas_Rubio JL, Rubio-Rivas M, Freire-Dapena M, Guillén-del Castillo A, Iniesta-Arandia N, Castillo-Palma MJ, Egurbide-Arberas M, Trapiellla-Martínez L, Vargas-Hitos JA, Todolí-Parra JA, Rodriguez-Carballeira M, Marin-Ballvé A, Pla-Salas X, Rios-Blanco JJ, Fonollosa-Pla V (2016) Digital ulcers and cutaneous subsets of systemic sclerosis: clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. Semin Arthritis Rheum 46:200–208PubMedGoogle Scholar
- 20.Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66:754–763PubMedPubMedCentralGoogle Scholar
- 21.Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21:42–46Google Scholar
- 23.Yao K-T, Lin C-C, Hung C-H (2009) Maximum mouth opening of ethnic Chinese in Taiwan. J Dent Sci 4:40–44Google Scholar
- 25.Hisli N (1989) The validity and reliability of the Beck Depression Inventory among university students. Turk J Psychol 7:3–13Google Scholar
- 30.Nazarinia MA, Esmaeilzadeh E, Emami Y, Salehi A (2016) One decade distinct features, morbidity and mortality of scleroderma: a cross-sectional study. Clin Exp Rheumatol 100(5):74–78Google Scholar
- 31.Steen V, Denton CP, Pope JE, Matucci-Cerinic M (2009) Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford) 48:19–24Google Scholar
- 32.Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C, RAPIDS-1 Study Group (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50:3985–3993PubMedGoogle Scholar
- 38.Baron M, Hudson M, Tatibouet S, Steele R, Lo E, Gravel S, Gyger G, El Sayegh T, Pope J, Fontaine A, Masetto A, Matthews D, Sutton E, Thie N, Jones N, Copete M, Kolbinson D, Markland J, Nogueira G, Robinson D, Fritzler M, Gornitsky M (2015) Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III. Arthritis Care Res 67:681–690Google Scholar
- 39.Thombs BD, Taillefer SS, Hudson M, Baron M (2007) Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis RheumAug 57(6):1089–1097Google Scholar
- 41.Faezi ST, Paragomi P, Shahali A, Akhlaghkhah M, Akbarian M, Akhlaghi M, Kheirandish M, Gharibdoost F (2017) Prevalence and severity of depression and anxiety in patients with systemic sclerosis: an epidemiologic survey and investigation of clinical correlates. J Clin Rheumatol 23(2):80–86PubMedGoogle Scholar
- 42.Thombs BD, Jewett LR, Kwakkenbos L, Hudson M, Baron M; Canadian Scleroderma Research Group (2015) Major depression diagnoses among patients with systemic sclerosis: baseline and one-month follow up. Arthritis Care Res 67(3):411–416Google Scholar
- 43.Haythornthwaite JA, Heinberg LJ, McGuire L (2003) Psychologic factors in scleroderma. Rheum Dis Clin N Am 29(2):427–439Google Scholar
- 45.Bodukam V, Hays RD, Maranian P, Furst DE, Seibold JR, Impens A, Mayes MD, Clements PJ, Khanna D (2011) Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology (Oxford) 50(2):330–334Google Scholar
- 46.Naidoo I, Charlton KE, Esterhuizen TM, Cassim B (2015) High risk of malnutrition associated with depressive symptoms in older South Africans living in KwaZulu-Natal, South Africa: a cross-sectional survey. J Health Popul Nutr 19:33Google Scholar
- 47.Roelofs J, van Breukelen G, de Graaf LE, Beck AT, Arntz A, Huibers MJH (2013) Norms for the Beck Depression Inventory (BDI-II) in a large Dutch community sample. J Psychopathol Behav Assess 35:93–98Google Scholar